Evidence map›Paper›PMID 27427453›Full record

ReviewLancet (London, England)2016

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Kate Dolan, Andrea L Wirtz, Babak Moazen, Martial Ndeffo-Mbah, Alison Galvani, Stuart A Kinner, Ryan Courtney, Martin McKee, Joseph J Amon, Lisa Maher and 3 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Lancet (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 315 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
315citing papers in PubMed, 18 pooled it
47.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

315 citing papers in PubMed, 18 syntheses or guidelines pooled it, 644 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence of overweight and obesity in incarcerated individuals in developed and developing countries: A systematic review and meta-analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Vaccination Coverage among Prisoners: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  18. Pooled it
  19. Trial
  20. Trial

255 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

Kate DolanNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia. Electronic address: k.dolan@unsw.edu.au.
Andrea L WirtzCenter for Public Health and Human Rights, Johns Hopkins School of Public Health, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Babak MoazenNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Martial Ndeffo-MbahCenter for Infectious Disease Modeling and Analysis, Yale University, New Haven, CT, USA.
Alison GalvaniCenter for Infectious Disease Modeling and Analysis, Yale University, New Haven, CT, USA.
Stuart A KinnerGriffith Criminology Institute & Menzies Health Institute Queensland, Griffith University, Brisbane, QLD, Australia.
Ryan CourtneyNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
Martin McKeeDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Joseph J AmonHealth and Human Rights Division, Human Rights Watch, New York, NY, USA.
Lisa MaherKirby Institute, University of New South Wales, Sydney, NSW, Australia.
Margaret HellardCentre for Population Health, Burnet Institute, Melbourne, VIC, Australia.
Chris BeyrerCenter for Public Health and Human Rights, Johns Hopkins School of Public Health, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Fredrick L AlticeEpidemiology and Public Health, Yale University, New Haven, CT, USA.
UNSW Sydney · AUYale University · USJohns Hopkins University · USBurnet Institute · AUGriffith University · AUHuman Rights Watch · USLondon School of Hygiene & Tropical Medicine · GBTehran University of Medical Sciences · IR

Funding

HIV, Buprenorphine, and the Criminal Justice SystemR01DA030768 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2010 to 2015
$4.0M
Intervention of HIV, Drug Use and the Criminal Justice System in MalaysiaR01DA025943 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2008 to 2012
$2.7M
Enhancing Health Outcomes Among HIV+ Substance AbusersK24DA017072 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2003 to 2012
$1.5M
NIDA NIH HHS K24 DA017072NIDA NIH HHS R01 DA025943NIDA NIH HHS R01 DA030768
6 · The paper itself

Abstract

The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration rate in people who inject drugs and providing opioid agonist therapy could reduce the burden of HIV in this population. The prevalence of HIV, HCV, HBV, and tuberculosis is higher in prison populations than in the general population, mainly because of the criminalisation of drug use and the detention of people who use drugs. The most effective way of controlling these infections in prisoners and the broader community is to reduce the incarceration of people who inject drugs.

Indexed as

Cost of IllnessGlobal HealthCoinfectionDisease OutbreaksDrug UsersHepatitis BHepatitis CHepatitis, Viral, HumanHIV InfectionsHumansPrevalencePrisonersSubstance Abuse, IntravenousTuberculosisUnited States

Identifiers

PMID27427453
OpenAlexW2473174975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.